Otto Hemminki

2.1k total citations
73 papers, 1.5k citations indexed

About

Otto Hemminki is a scholar working on Oncology, Genetics and Surgery. According to data from OpenAlex, Otto Hemminki has authored 73 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 49 papers in Oncology, 31 papers in Genetics and 23 papers in Surgery. Recurrent topics in Otto Hemminki's work include Virus-based gene therapy research (28 papers), CAR-T cell therapy research (26 papers) and Immunotherapy and Immune Responses (11 papers). Otto Hemminki is often cited by papers focused on Virus-based gene therapy research (28 papers), CAR-T cell therapy research (26 papers) and Immunotherapy and Immune Responses (11 papers). Otto Hemminki collaborates with scholars based in Finland, Germany and Czechia. Otto Hemminki's co-authors include Akseli Hemminki, João M. Santos, Anna Kanerva, Kari Hemminki, Asta Försti, Vincenzo Cerullo, Timo Joensuu, Ilkka Liikanen, Anniina Koski and Minna Oksanen and has published in prestigious journals such as PLoS ONE, Scientific Reports and Annals of Oncology.

In The Last Decade

Otto Hemminki

72 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Otto Hemminki Finland 20 908 857 468 292 232 73 1.5k
J. Andrea McCart Canada 17 722 0.8× 1.1k 1.3× 480 1.0× 256 0.9× 240 1.0× 35 1.5k
J. Andrea McCart Canada 15 608 0.7× 759 0.9× 343 0.7× 161 0.6× 188 0.8× 22 1.1k
Guy Ungerechts Germany 27 1.2k 1.3× 1.5k 1.8× 782 1.7× 410 1.4× 228 1.0× 62 2.3k
Dechao Yu United States 27 1.2k 1.3× 1.5k 1.8× 1.4k 3.0× 382 1.3× 428 1.8× 57 2.7k
Lihua Tao United States 21 627 0.7× 534 0.6× 541 1.2× 281 1.0× 79 0.3× 51 1.3k
Mena Mansour United States 11 684 0.8× 565 0.7× 354 0.8× 349 1.2× 110 0.5× 23 1.2k
Melinda VanRoey United States 18 768 0.8× 412 0.5× 707 1.5× 552 1.9× 124 0.5× 21 1.4k
Kelley A. Parato Canada 15 1.2k 1.3× 1.7k 2.0× 815 1.7× 442 1.5× 350 1.5× 17 2.0k
Yosuke Kawakami Japan 19 468 0.5× 617 0.7× 556 1.2× 122 0.4× 108 0.5× 42 1.1k
Matthias Karrasch Germany 16 576 0.6× 623 0.7× 486 1.0× 197 0.7× 110 0.5× 42 1.5k

Countries citing papers authored by Otto Hemminki

Since Specialization
Citations

This map shows the geographic impact of Otto Hemminki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Otto Hemminki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Otto Hemminki more than expected).

Fields of papers citing papers by Otto Hemminki

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Otto Hemminki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Otto Hemminki. The network helps show where Otto Hemminki may publish in the future.

Co-authorship network of co-authors of Otto Hemminki

This figure shows the co-authorship network connecting the top 25 collaborators of Otto Hemminki. A scholar is included among the top collaborators of Otto Hemminki based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Otto Hemminki. Otto Hemminki is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Grönberg-Vähä-Koskela, Susanna, Dafne C.A. Quixabeira, João M. Santos, et al.. (2025). Oncolytic adenovirus encoding variant interleukin-2 combined with chemotherapy enables PD-L1 inhibition in pancreatic cancer models. Cancer Immunology Immunotherapy. 74(7). 234–234. 1 indexed citations
2.
Hemminki, Kari, et al.. (2024). Age-Specific Survival in Lung Cancer in the Nordic Countries through a Half Century. Journal of Biomedical Research & Environmental Sciences. 5(8). 996–1005. 1 indexed citations
3.
Hemminki, Kari, Lambertus A. Kiemeney, Alicia K. Morgans, et al.. (2024). Hereditary and Familial Traits in Urological Cancers and Their Underlying Genes. European Urology Open Science. 69. 13–20. 1 indexed citations
4.
Koskinen, Anni, et al.. (2024). Survival in oral and pharyngeal cancers is catching up with laryngeal cancer in the NORDIC countries through a half century. Cancer Medicine. 13(1). e6867–e6867. 6 indexed citations
5.
Hemminki, Kari, Kristina Sundquist, Jan Sundquist, et al.. (2024). Critical survival periods in prostate cancer in Sweden explored by conditional survival analysis. Cancer Medicine. 13(7). e7126–e7126. 1 indexed citations
6.
Hemminki, Kari, et al.. (2024). Survival improvements in esophageal and gastric cancers in the Nordic countries favor younger patients. Cancer Medicine. 13(15). e7365–e7365. 1 indexed citations
7.
Försti, Asta, et al.. (2023). Conditional Survival in Prostate Cancer in the Nordic Countries Elucidates the Timing of Improvements. Cancers. 15(16). 4132–4132. 3 indexed citations
8.
Tichánek, Filip, Asta Försti, Akseli Hemminki, Otto Hemminki, & Kari Hemminki. (2023). Long-Term Periodic and Conditional Survival Trends in Prostate, Testicular, and Penile Cancers in the Nordic Countries, Marking Timing of Improvements. Cancers. 15(17). 4261–4261. 1 indexed citations
9.
Tichánek, Filip, Asta Försti, Akseli Hemminki, Otto Hemminki, & Kari Hemminki. (2023). Survival in melanoma in the nordic countries into the era of targeted and immunological therapies. European Journal of Cancer. 186. 133–141. 10 indexed citations
10.
Koskinen, Anni, Otto Hemminki, Asta Försti, & Kari Hemminki. (2022). Incidence and survival in oral and pharyngeal cancers in Finland and Sweden through half century. BMC Cancer. 22(1). 227–227. 12 indexed citations
11.
Koskinen, Anni, Otto Hemminki, Asta Försti, & Kari Hemminki. (2022). Incidence and survival in laryngeal and lung cancers in Finland and Sweden through a half century. PLoS ONE. 17(5). e0268922–e0268922. 12 indexed citations
12.
Zafar, Sadia, Dafne C.A. Quixabeira, João M. Santos, et al.. (2020). Oncolytic Adenovirus Type 3 Coding for CD40L Facilitates Dendritic Cell Therapy of Prostate Cancer in Humanized Mice and Patient Samples. Human Gene Therapy. 32(3-4). 192–202. 21 indexed citations
13.
Zhang, Luyao, Otto Hemminki, Tianhui Chen, et al.. (2019). Second cancers and causes of death in patients with testicular cancer in Sweden. PLoS ONE. 14(3). e0214410–e0214410. 16 indexed citations
14.
Cerullo, Vincenzo, Cristian Capasso, Markus Vähä‐Koskela, Otto Hemminki, & Akseli Hemminki. (2018). Cancer-Targeted Oncolytic Adenoviruses for Modulation of the Immune System. Current Cancer Drug Targets. 18(2). 124–138. 16 indexed citations
15.
Hemminki, Otto, et al.. (2018). Familial Urinary Bladder Cancer with Other Cancers. European Urology Oncology. 1(6). 461–466. 3 indexed citations
16.
Hemminki, Kari, Otto Hemminki, Asta Försti, et al.. (2017). Surveillance Bias in Cancer Risk After Unrelated Medical Conditions: Example Urolithiasis. Scientific Reports. 7(1). 8073–8073. 21 indexed citations
17.
Hemminki, Kari, Asta Försti, Raimo Tuuminen, et al.. (2016). The Incidence of Senile Cataract and Glaucoma is Increased in Patients with Plasma Cell Dyscrasias: Etiologic Implications. Scientific Reports. 6(1). 28500–28500. 10 indexed citations
18.
Hemminki, Otto, Iulia Diaconu, Vincenzo Cerullo, et al.. (2012). Ad3-hTERT-E1A, a Fully Serotype 3 Oncolytic Adenovirus, in Patients With Chemotherapy Refractory Cancer. Molecular Therapy. 20(9). 1821–1830. 62 indexed citations
19.
Liikanen, Ilkka, Vladia Monsurrò, Laura Ahtiainen, et al.. (2011). Induction of Interferon Pathways Mediates In Vivo Resistance to Oncolytic Adenovirus. Molecular Therapy. 19(10). 1858–1866. 39 indexed citations
20.
Norrdahl, Kai, et al.. (1995). Predator presence may benefit: kestrels protect curlew nests against nest predators. Oecologia. 101(1). 105–109. 46 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by J. Andrea McCart Breakdown of academic impact, for papers by J. Andrea McCart Breakdown of academic impact, for papers by Guy Ungerechts Breakdown of academic impact, for papers by Dechao Yu Breakdown of academic impact, for papers by Lihua Tao Breakdown of academic impact, for papers by Mena Mansour Breakdown of academic impact, for papers by Melinda VanRoey Breakdown of academic impact, for papers by Kelley A. Parato Breakdown of academic impact, for papers by Yosuke Kawakami Breakdown of academic impact, for papers by Matthias Karrasch
Rankless by CCL
2026